Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0752347 (
Dementia with Lewy bodies
)
1,653
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
G-protein coupled receptor kinases (GRKs) constitute a serine/threonine kinase family playing a major role in agonist-induced phosphorylation and desensitization of G-protein coupled receptors. Recently,
GRK2
and GRK5 have been demonstrated to phosphorylate alpha-synuclein (Ser129) and other synuclein isoforms. We studied colocalization of
GRK2
, GRK5, alpha-synuclein, and tau in neurodegenerative disorders characterized by fibrillary tau inclusions and/or alpha-synuclein-enriched Lewy bodies. We found that Lewy bodies were negative for both
GRK2
and GRK5 in
Lewy body disease
(
LBD
) and
LBD
mixed with Alzheimer disease (AD +
LBD
). Instead,
GRK2
but not GRK5 colocalized with 40% to 50% of neurofibrillary tangles in AD +
LBD
and AD brains. In disorders with less prominent alpha-synucleinopathy, neuronal and glial fibrillary tau deposits known to contain distinct subsets of tau isoforms were also positive for
GRK2
. These deposits included tufted astrocytes and coiled bodies in progressive supranuclear palsy, astrocytic plaques in corticobasal degeneration, and Pick bodies in Pick disease. In addition, paired helical filaments isolated from AD and AD +
LBD
brains were found to immunogold-label for
GRK2
, suggesting that
GRK2
could be a potential tau kinase associated with fibrillary tau. Our studies indicate that
GRK2
is a novel component of neuronal and glial fibrillary tau deposits with no preference in tau isoform binding.
GRK2
may play a role in hyperphosphorylation of tau in tauopathies.
...
PMID:Identification of G-protein coupled receptor kinase 2 in paired helical filaments and neurofibrillary tangles. 1714 90